Wake Forest University Health Sciences v Smith & Nephew Pty Ltd (No 2)

Link copied
Case Copied 74 min read

FEDERAL COURT OF AUSTRALIA

Wake Forest University Health Sciences v Smith & Nephew Pty Ltd (No 2) [2011] FCA 1002

Citation: Wake Forest University Health Sciences v Smith & Nephew Pty Ltd (No 2) [2011] FCA 1002
Parties: WAKE FOREST UNIVERSITY HEALTH SCIENCES and KCI MEDICAL AUSTRALIA PTY LTD (ACN 056 073 468) v SMITH & NEPHEW PTY LTD (ACN 000 087 507); SMITH & NEPHEW PTY LTD (ACN 000 087 507); WAKE FOREST UNIVERSITY HEALTH SCIENCES and KCI MEDICAL AUSTRALIA PTY LTD (ACN 056 073 468)
File number: VID 143 of 2009
Judge: DODDS-STREETON J
Date of judgment: 30 August 2011
Catchwords:

PATENTS – Method and apparatus for treating wounds unlikely to heal by the use of conventional methods through negative pressure wound therapy – Common general knowledge as at priority date – Construction of claims – Meaning of integer of screen means “sufficiently rigid to prevent wound overgrowth” – Meaning of integer of screen means “sufficiently porous” to allow gases or oxygen to reach the wound – Meaning of integer of “migration of epithelial and subcutaneous tissue toward the wound” – Whether various integers essential

PATENTS – Infringement – Whether direct or indirect infringement – Whether respondent liable as joint tortfeasor – Whether respondent’s products possessed screen means sufficiently rigid to prevent wound overgrowth – Whether respondent’s products possessed other integers

PATENTS – Validity – Novelty – Whether prior art anticipated claims in suit – Whether claims in suit anticipated by prior use of open drainage system

PATENTS – Validity – Inventive step – Whether invention obvious to skilled addressee – Construction of Patents Act 1990 (Cth) ss 7(2) and (3) – Whether prior art comparator to be considered as starting point for obviousness

PATENTS – Validity – Other grounds of alleged invalidity – Whether claims in suit fairly based on matter described in specification – Whether priority date deferred – Whether invention a manner of manufacture or comprised of mere clinical desiderata – Whether invention properly defined – Whether claims invalid for lack of clarity – Whether claims invalid for lack of sufficiency – Whether claim invalid as a mere collocation

Legislation:

Evidence Act 1995 (Cth) s 140
Patents Act 1990 (Cth) ss 7, 13, 18(1), 40(2), 40(3), 102(2)(a), 114, 117, 138(3), Schedule 1

Patents Regulations 1991 (Cth) reg 3.14

Cases cited:

Abbott Laboratories & Anor v Corbridge Group Pty Ltd & Anor (2002) 57 IPR 432 cited
Advanced Building Systems Pty Ltd & Anor v Ramset Fasteners (Aust) Pty Ltd (1998) 194 CLR 171 cited
Ajinomoto Company Inc v NutraSweet Australia Pty Ltd (2008) 166 FCR 530 cited
Aktiebolaget Hässle v Alphapharm Pty Ltd (2000) 51 IPR 375 cited
Aktiebolaget Hässle & Anor v Alphapharm Pty Ltd (2002) 212 CLR 411 discussed
Alphapharm Pty Ltd v H Lundbeck A/S & Anor (2008) 76 IPR 618 cited
Anaesthetic Supplies Pty Ltd v Rescare Ltd (1994) 50 FCR 1 considered
Apotex Pty Ltd v Sanofi Aventis (2008) 78 IPR 485 cited
Apotex Pty Ltd v Sanofi-Aventis (2009) 82…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Wake Forest University Health Sciences v Smith & Nephew Pty... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2011] FCA 1002
Decision Date

CaseChat Overview and Summary

In the case of Wake Forest University Health Sciences v Smith & Nephew Pty Ltd (No 2), the primary dispute centred on the validity and infringement of a patent related to a method and apparatus for treating wounds using negative pressure wound therapy. The court had to determine whether Smith & Nephew Pty Ltd (S&N) had infringed the patent held by Wake Forest University Health Sciences (WFUHS) and whether the patent was valid. The patent in question, titled "Method and Apparatus for Treating Tissue Damage," had 123 claims, with 14 combination claims in suit that related to either a method of treatment or an apparatus. These claims included integers such as a sufficiently rigid and porous screen means, migration of epithelial and subcutaneous tissue toward the wound, and other specific attributes.

The central legal issues involved the construction of the patent claims, the infringement of these claims by S&N's products, and the validity of the claims under the Patents Act 1990 (Cth). The court had to decide whether the claims were clear and sufficiently described, whether they were novel and inventive, and whether they were anticipated by prior art. The claims' validity also depended on whether they were fairly based on the matter described in the specification, whether the invention was a manner of manufacture, and whether the claims were clear and sufficient. The court had to determine if S&N's products directly or indirectly infringed the patent and whether S&N was liable as a joint tortfeasor.

The court found that the claims were invalid due to the essential integer of screen rigidity being fundamentally flawed, as it lacked clarity and specificity. This flaw rendered the claims invalid under sections 40(2) and (3) of the Patents Act 1990 (Cth). The court concluded that the skilled addressee would attribute no meaning to this integer, which was crucial for the validity of the claims. Consequently, the court ruled that the application should be dismissed, and the cross-claim should be allowed. The court invited submissions on the form of orders and costs.

Orders

Orders of the court

Background

Background to the litigation

As S&N acknowledged, because the essential screen rigidity integer common to all the combination claims could not be established, its challenge to the validity of the claims based on novelty necessarily failed (as the purported integer was absent from the prior art). Nor, in my view, did S&N establish that the claims were invalid on the ground of obviousness (lack of inventive step). The fundamentally flawed nature of the screen rigidity integer nevertheless, in my view, rendered all the claims invalid on the basis of failure to satisfy the requirements of ss 40(2) and (3) of the Patents Act 1990 (Cth) (“the Act”) that, inter alia, they be clear and sufficient, as, despite the evidence of KCI’s expert witnesses, the evidence as a whole established that the skilled addressee would attribute no meaning to the integer. This was thus a rare case where fundamental lack of clarity in an essential integer rendered the claims invalid.Background WFUHS is the proprietor of the Patent, which is described in more detail further below (see [33] to [67]) and briefly summarised here. KCI MA is the exclusive Australian licensee of the invention, which carries out its commercial exploitation. In summary, the invention includes both a medical apparatus and a method for applying negative pressure to wounds which are unlikely to heal completely or at all by the use of conventional means. The Patent is entitled “Method and Apparatus for Treating Tissue Damage”. It has a total of 123 claims in all and 18 independent claims, directed to the five aspects of the invention. The 14 claims in suit are all combination claims with multiple integers. They relate to either of two aspects of the invention, namely a method of treatment or an apparatus. At the outset, there were 40 claims in suit, which expanded to 70, reduced to 16, and ultimately reduced to the 14 claims remaining in issue. The invention was made at Wake Forest University in North Carolina, USA by Dr Louis Argenta, a plastic surgeon, and Dr Michael Morykwas, a bioengineer. The Patent has a priority date of 14 November 1991 (subject to S&N’s cross‑claim discussed below, which alleges a deferred priority date of 7 November 1996). The Patent results from an application under the Patent Co‑operation Treaty (“PCT”) no. PCT/US92/09649 filed on 12 November 1992, claiming priority from US Application No. 792001, filed on 14 November 1991. (By s 88 of the Act, the PCT application is treated as a complete application for a standard patent). As filed, the specification had 52 claims. When the application was examined by the Commissioner of Patents, the Examiner, pursuant to s 45 of the Act, reported that “there are lawful grounds of objection to… the complete specification”, because, broadly, specified claims did not define the invention as described. Thus, while the specification, as a whole, indicated that a “screen means” or dressing, made of material sufficiently porous to allow oxygen to reach the wound and sufficiently rigid to prevent wound overgrowth, was part of the invention, the claims did not include that feature.

Evidence

Evidence Before The Court

A fact does not form part of the common general knowledge merely because it is known or even well known. Nor does the use of something per se qualify it, as Luxmore J in British Acoustic (cited by the Court of Appeal in General Tire at 135) stated at 250: It is certainly difficult to appreciate how the use of something which has in fact never been used in a particular art can ever be held to be common general knowledge in the art. Parties’ submissions and expert evidence The parties differed on the common general knowledge about the treatment of wounds prior to November 1991. KCI contended that:(a)Passive drainage of closed sutured wounds was common. While there was also active drainage of closed wounds by RediVac or HemoVac bottles, wall suction or portable pumps, it was a rare practice which involved practical difficulties.(b)The drainage of open wounds was not common, although Professor Marshall used a passive sump system or device on open wounds. (c)The active drainage of fistulae and open wounds to which Dr Williams and Dr Pohl testified was neither widespread nor common general knowledge.(d)Further, Dr Williams’ practice involved fistulae, which were not “wounds” proper, and the focus was on removing effluent, rather than using negative pressure for the trilogy of purposes expressed in the Patent.(e)While Dr Williams’ veracity was unchallenged, his evidence about the active drainage of fistulae and open wounds contrasted with the ignorance of the practice expressed by Mr Ellis (a highly experienced wounds nurse working for some of the time in the same hospital) and Professor Marshall, and the fact that Professor Penington and Professor Stacey used drainage only on closed wounds and had neither seen nor used Dr Williams’ technique.(f)Ultimately, only Dr Williams and Dr Pohl had used active suction on open wounds or seen it used prior to 1991.(g)Further, while there was a range of dressings, gauze was most commonly used and foams, while available, had limited application, mainly confined to skin grafts and diabetic ulcers.(h)Foam was not, on the evidence, placed in wounds and used in conjunction with negative pressure to achieve promotion of granulation tissue, prevention of wound overgrowth and drawing the wound closed.(i)Gauze was used on the top of, and to pack, wounds.(j)Covers or films were used to keep wounds moist, but subject to frequent dressing changes. S&N contended that the evidence of Dr Williams, fortified by that of Mr Osmond, established that active drainage of open wounds with underlying fistulae and other moderate to heavily draining wounds occurred from at least the 1970s and as at 1991 and indeed, in some hospitals, fistulae and moderate to heavily draining open wounds were treated with open drainage suction comprising the following:(a)a porous dressing laid across the surface of the wound in such a way so as to pack it;(b)a tube laid on top of the porous dressing or across the wound beneath a gauze dressing;(c)a cover such as a stoma bag or long bag or flexible plastic bag, which was attached to the skin surrounding the wound with an adhesive such as Stomahesive paste or Stomahesive tape to create an air tight cover over the wound or an adhesive film or adhesive dressing; and(d)a tube which exited the cover in such a way so as to maintain the seal over the wound and which was attached to a source of suction, generally wall suction or a portable electric pump, which system would be left in place for as long as required, depending on the nature of the wound, typically until ready for standard wound dressings. The system would be applied for a variable length of time depending on the nature of the wound.

Decision

Reasons for decision

On that basis, I was not persuaded that the above impugned integers were not fairly based on matter described in the specification. conclusion In my opinion, the application should be dismissed and the cross-claim should be allowed. I shall invite submissions on the form of orders and costs.

Ratio Decidendi

Legal Principle Established